Monocytes express at least two different classes of cell-type specific genes. One class, exemplified gy the M-CSF receptor gene, c-fms, is constitutively expressed and dependent upon the differentiated state. Another class, represented by the IL-1beta gene (il1b), is also generally monocyte-specific, but is only expressed immediately in response to a stimulation event that parallels the conversion of the resting monocyte to the activated monocyte/macrophage. Investigation of the il1b regulation mechanisms have revealed two distinct and separable regions of the gene that correspond to each of the two criteria, a cell type specific 143bp basal promoter and a signal-responsive upstream enhancer. The enhancer function depends upon the cooperative function of several broadly expressed signal-responsive transcription factors (e.g., C/EBPbeta, CREB, c-Jun, and NF- kappaB), including a novel STAT-like factor, whereas the 71 bp basal promoter appears to depend upon binding of one molecule of the mono-myeloid factor Spi-1/PU.1 (Spi-1), a factor that plays a central key role in monocyte development and cell type-specific gene expression. The functional interaction between the basal promoter and an enhancer requires a critical additional 73bp element that requires the binding of an additional Spi-1 molecule. This element is not required for enhancer-independent activity in the presence of IE2, a cytomegalovirus protein. IE2 appears to interact directly with the Spi-1 ETS domain. This region is found in all ETS proteins and mediates associations with a broad range of other proteins, modulating function in both partners. The object of this proposal is to elucidate the mechanism by which Spi-1 interacts with other proteins and integrates enhancer function into the core promoter and to attempt to clone the novel STAT-like factor that is activated in response to LPS, IL-1, and IL-6.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
5R01CA068544-12
Application #
6752406
Study Section
Experimental Immunology Study Section (EI)
Program Officer
Howcroft, Thomas K
Project Start
1995-08-25
Project End
2006-05-31
Budget Start
2004-06-01
Budget End
2006-05-31
Support Year
12
Fiscal Year
2004
Total Cost
$233,953
Indirect Cost
Name
University of Pittsburgh
Department
Genetics
Type
Schools of Medicine
DUNS #
004514360
City
Pittsburgh
State
PA
Country
United States
Zip Code
15213
Pulugulla, Sree H; Workman, Riley; Rutter, Nathan W et al. (2018) A combined computational and experimental approach reveals the structure of a C/EBP?-Spi1 interaction required for IL1B gene transcription. J Biol Chem 293:19942-19956
Listman, James A; Race, JoAnne E; Walker-Kopp, Nancy et al. (2008) Inhibition of IL-1beta transcription by peptides derived from the hCMV IE2 transactivator. Mol Immunol 45:2667-77
Unlu, Sebnem; Kumar, Arvind; Waterman, Wayne R et al. (2007) Phosphorylation of IRF8 in a pre-associated complex with Spi-1/PU.1 and non-phosphorylated Stat1 is critical for LPS induction of the IL1B gene. Mol Immunol 44:3364-79
Wang, Kent Z Q; Wara-Aswapati, Nawarat; Boch, Jason A et al. (2006) TRAF6 activation of PI 3-kinase-dependent cytoskeletal changes is cooperative with Ras and is mediated by an interaction with cytoplasmic Src. J Cell Sci 119:1579-91
Waterman, Wayne R; Xu, Li Lian; Tetradis, Sotirios et al. (2006) Glucocorticoid inhibits the human pro-interleukin lbeta gene (ILIB) by decreasing DNA binding of transactivators to the signal-responsive enhancer. Mol Immunol 43:773-82
Listman, James A; Wara-aswapati, Nawarat; Race, JoAnne E et al. (2005) Conserved ETS domain arginines mediate DNA binding, nuclear localization, and a novel mode of bZIP interaction. J Biol Chem 280:41421-8
Yoshida, Yasuhiro; Kumar, Arvind; Koyama, Yoshinobu et al. (2004) Interleukin 1 activates STAT3/nuclear factor-kappaB cross-talk via a unique TRAF6- and p65-dependent mechanism. J Biol Chem 279:1768-76
Boch, Jason A; Yoshida, Yasuhiro; Koyama, Yoshinobu et al. (2003) Characterization of a cascade of protein interactions initiated at the IL-1 receptor. Biochem Biophys Res Commun 303:525-31
Tan, Lujian; Peng, Haibing; Osaki, Makoto et al. (2003) Egr-1 mediates transcriptional repression of COL2A1 promoter activity by interleukin-1beta. J Biol Chem 278:17688-700
Osaki, Makoto; Tan, Lujian; Choy, Bob K et al. (2003) The TATA-containing core promoter of the type II collagen gene (COL2A1) is the target of interferon-gamma-mediated inhibition in human chondrocytes: requirement for Stat1 alpha, Jak1 and Jak2. Biochem J 369:103-15

Showing the most recent 10 out of 20 publications